Прескочи към материала

Ортопедична хирургия

Управление и оптимизация на хемостазата

Антифибринолитични средства

Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty. (отваря нов прозорец)

Banerjee S, Issa K, Pivec R, McElroy MJ, Khanuja HS, Harwin SF, Mont MA.

Източник‎: J Knee Surg 2013;26(6):379-85.

Статията е индексирана‎: PubMed 23955184

DOI‎: 10.1055/s-0033-1353992

https://www.ncbi.nlm.nih.gov/pubmed/23955184 (отваря нов прозорец)

Tranexamic acid in patients undergoing noncardiac surgery. (отваря нов прозорец)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

Източник‎: N Engl J Med. 2022;386(21):1986-97.

Статията е индексирана‎: PubMed 35363452

DOI‎: 10.1056/NEJMoa2201171

https://pubmed.ncbi.nlm.nih.gov/35363452/ (отваря нов прозорец)

Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. (отваря нов прозорец)

Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M.

Източник‎: Int Orthop 2013;37(3):441-5.

Статията е индексирана‎: PubMed 23371424

DOI‎: 10.1007/s00264-013-1787-7

https://www.ncbi.nlm.nih.gov/pubmed/23371424 (отваря нов прозорец)

The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. (отваря нов прозорец)

Lin SY, Chen CH, Fu YC, Huang PJ, Chang JK, Huang HT.

Източник‎: J Arthroplasty 2015;30(5):776-80.

Статията е индексирана‎: PubMed 25534864

DOI‎: 10.1016/j.arth.2014.12.001

https://www.ncbi.nlm.nih.gov/pubmed/25534864 (отваря нов прозорец)

Oral is as effective as intravenous tranexamic acid at reducing blood loss in thoracolumbar spinal fusions: a prospective randomized trial. (отваря нов прозорец)

Yu CC, Fidai M, Washington T, Bartol S, Graziano G

Източник‎: Spine 2022;47(2):91-8.

Статията е индексирана‎: PubMed 34224510

DOI‎: 10.1097/BRS.0000000000004157

https://pubmed.ncbi.nlm.nih.gov/34224510/ (отваря нов прозорец)

Активиран рекомбинантен фактор VII (rFVIIa)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (отваря нов прозорец)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Източник‎: Spine 2004;29(12):1384-7.

Статията е индексирана‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (отваря нов прозорец)

Локални хемостатични средства

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (отваря нов прозорец)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Източник‎: Ann Surg 2010;251(2):217-28.

Статията е индексирана‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (отваря нов прозорец)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (отваря нов прозорец)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Източник‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Статията е индексирана‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (отваря нов прозорец)

The efficacy of bone wax in reduction of perioperative blood loss in total hip arthroplasty via direct anterior approach: a prospective randomized clinical trial. (отваря нов прозорец)

Mortazavi SMJ, Razzaghof M, Ghadimi E, Seyedtabaei SMM, Vahedian Ardakani M, Moharrami A

Източник‎: J Bone Joint Surg Am. 2022;104(20):1805-13.

Статията е индексирана‎: PubMed 35984033

DOI‎: 10.2106/JBJS.22.00376

https://pubmed.ncbi.nlm.nih.gov/35984033/ (отваря нов прозорец)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (отваря нов прозорец)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Източник‎: Int Orthop 2019;43(12):2707-14.

Статията е индексирана‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (отваря нов прозорец)